中文 EN
聯絡我們 聯絡我們

TRAINING COURSES

培訓課程

AI藥物發展

AI藥物發展

課程上課地點

課程報名日 2026-05-13 ~ 2026-06-01

課程開始與結束日 2026-06-05 14:00 ~ 2026-06-05 16:00

上課講師 顧德諮詢有限公司/顧曼芹總經理

◇ COURSE SYLLABUS
  1. 以終為始的藥物發展策略
  2. AI藥物發展概念
  3. 未來發展趨勢
◇ INSTRUCTOR﹍ DR. MANNCHING SHERRY KU


◇ POSITION﹍ GM OF KUDER CONSULTING INC.


◇ EDUCATION
 
  • 9/78-9/83 Ph.D. in Pharmaceutics & Pharmaceutical Chemistry, The Ohio State University - GPA 3.88. Ph.D. Thesis on ADME including metabolite synthesis and C14 tissue distribution of Anticancer NCI contact Nucleosides under Professor Lou Malspeis.
  • in Pharmacy, B.S.9/74-6/78 National Taiwan University

◇ EXPERIENCE
 
  • Chairman of Board and Chief Executive Officer (CEO), Savior Lifetec Corp.
  • Founding President and Board member of Ruenhuei Biopharmaceuticals, Inc.
  • Founding President/CSO/Board member, TWi Biotech and TWi Pharma Inc.
  • Pfizer Co, Pearl River, NY 10965 (previously Wyeth Research/American Cyanamid/Lederle)
  • Vice Chairman, New Jersey Pharmaceutical Discussion Group
  • Member of the Executive Yuan Biotechnology Industry Strategy Advisory Committee (BTC)
  • In the 29-year tenure, she was promoted through the achievements: Developed more than 170 new clinical drugs, IND clinical research applications for 85 innovative new compounds and drugs, Successfully developed 9 marketed drugs, ect..

REGISTRATION FORM 報名表單

課程上課地點

課程報名日 2026-05-13 ~ 2026-06-01

課程開始與結束日 2026-06-05 14:00 ~ 2026-06-05 16:00

上課講師 顧德諮詢有限公司/顧曼芹總經理